News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
92 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44432)
2016 (38329)
2017 (37188)
2018 (39119)
2019 (51334)
2020 (57663)
2021 (58720)
2022 (53928)
2023 (42564)
2024 (37441)
2025 (33091)
2026 (18648)
Month
January (2433)
February (2866)
March (3029)
April (3115)
May (3356)
June (2725)
July (1124)
Day
1 (214)
2 (187)
3 (160)
4 (138)
5 (74)
7 (52)
8 (139)
9 (151)
10 (114)
11 (132)
12 (58)
14 (27)
15 (145)
16 (92)
17 (98)
18 (106)
19 (70)
21 (14)
22 (92)
23 (109)
24 (105)
25 (106)
26 (50)
28 (28)
29 (103)
30 (161)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
Day
1
2
3
4
5
7
8
9
10
11
12
14
15
16
17
18
19
21
22
23
24
25
26
28
29
30
Psychedelics
Definium’s LSD-based therapy elicits ‘profound’ efficacy in Phase 3 depression trial
Results for Definium Therapeutics psychedelic candidate for major depressive disorder “exceeded expectations,” according to Stifel, while Jefferies called the efficacy data “profound.”
June 22, 2026
·
2 min read
·
Michael Gibney
Press Releases
Biomerics Appoints Kristin Mason as Chief Financial Officer
June 22, 2026
·
2 min read
Press Releases
New Alzheimer’s & Dementia Paper Highlights SpeechDx’s Role in Advancing AI-Driven Tools for Earlier Alzheimer’s Detection and Risk Assessment
June 22, 2026
·
4 min read
Press Releases
Biocom’s 2026 Economic Impact Report Highlights the Strength, Resilience and Future of the Life Science Industry in California
June 22, 2026
·
4 min read
Press Releases
Zealand Pharma - Transactions related to share buy-back program (week 25, 2026)
June 22, 2026
·
3 min read
Press Releases
Lilly declares third-quarter 2026 dividend
June 22, 2026
·
2 min read
Press Releases
Yellowbird Diagnostics Completes Dosing in First-in-Human Phase 1 Trial of NeuCaVis(TM)
Human data demonstrates translation of key findings from preclinical studies
June 22, 2026
·
2 min read
Press Releases
Phanes Therapeutics Announces Completion of Enrollment in Phase 2 Clinical Trial of Spevatamig in Combination with Chemotherapy for the Frontline Treatment of Metastatic Pancreatic Ductal Adenocarcinoma
June 22, 2026
·
4 min read
Press Releases
PorTal Access Announces FDA Clearance of FLEXI-PORT™ family of implantable vascular access ports
June 22, 2026
·
3 min read
Press Releases
Alcami Expands Quality, Packaging, and Storage Capabilities at Tennessee Facility
June 22, 2026
·
2 min read
Previous
9 of 10
Next
